Systematic Review and Meta-Analysis of Peripheral Nerve Blocks for Treating Medication-Overuse Headache
Clinical Scorecard: Systematic Review and Meta-Analysis of Peripheral Nerve Blocks for Treating Medication-Overuse Headache
At a Glance
Category Detail
Condition Medication-Overuse Headache (MOH) Key Mechanisms Central and peripheral sensitization, alterations in pain modulation. Target Population Individuals with primary headache disorders overusing analgesics or triptans. Care Setting Outpatient settings, specialized headache clinics.
Key Highlights
MOH affects 0.5% to 7.2% of the global population, predominantly women aged 30 to 50. Peripheral nerve blocks can reduce headache intensity by up to 45% within 30 minutes. Greater occipital nerve block shows efficacy in reducing attack frequency in chronic migraine. Failure rates of occipital nerve block in MOH can reach up to 44%. Peripheral nerve block is not yet established as a sole therapy for MOH. Guideline-Based Recommendations
Diagnosis
Diagnosis based on ICHD-3 criteria for medication-overuse headache. Management
Detoxification through withdrawal of overused medications and initiation of preventive treatment. Monitoring & Follow-up
Monitor headache intensity, frequency, and quality of life post-intervention. Risks
Potential adverse effects include nerve injury, infection, hematoma, and systemic toxicity. Patient & Prescribing Data
Patients with medication-overuse headache.
Peripheral nerve blocks may serve as a transitional therapy during detoxification.
Clinical Best Practices
Educate patients and families about medication overuse and its consequences. Consider peripheral nerve blocks as part of a comprehensive treatment plan. Related Resources & Content
